Keymed Biosciences Inc. (2162.HK) HKSE

74.50

-1.2(-1.59%)

Updated at October 03 04:08PM

Currency In HKD

Valuation

Market Cap7.6B
Enterprise Value7.94B
P/E Ratio-69.62
PEG Ratio-1.39
Price/Sales Ratio23.03
Price/Book Ratio5.61
Enterprise/Revenue22.95
Enterprise/EBITDA-64.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.3
Operating Margin-0.4

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.09

Income Statement

Revenue428.12M
Revenue/Share3.32
Gross Profit415.92M
EBITDA-574.46M
Net Income-515.24M
Diluted EPS-1.97

Balance Sheet

Total Cash2.8B
Total Cash/Share10.56
Total Debt872.3M
Total Debt/Equity0.27
Current Ratio3.95
Book Value Per Share12.16

Price History

52-Week Change66.48
52-Week High80
52-Week Low27.05
Moving Average 50 Days71.01
Moving Average 200 Days47.51

Statistics

Average Volume3.98M
Shares Outstanding294.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A